Search results
Genentech’s Phase III STARGLO Study Demonstrates Columvi... With Relapsed or Refractory Diffuse...
Morningstar· 3 days agoGenentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell ...
EHA 2024: Odronextamab shows promise in ELM-2 study for follicular lymphoma
Clinical Trials Arena via Yahoo Finance· 1 day agoFollicular lymphoma (FL) is a chronic disease that accounts for about 20% of non-Hodgkin's lymphoma
Campaign fuels efforts to find better treatments for blood cancers in children
NBC Dallas Fort Worth· 4 hours agoLeukemia and Lymphoma Society's (LLS) Dare to Dream project hopes to raise money for research of...
EHA 2024: AstraZeneca’s Calquence plus chemoimmunotherapy offers new standard for MCL
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe trial results suggest that this Calquence combination therapy could...shows potential to extend...
What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday? - Nurix Therapeutics...
Benzinga· 1 day agos JNJ Imbruvica (Ibrutinib), and AstraZeneca Plc’s AZN Calquence (Acalabrutinib). NX-5948 is being...
Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
Zacks via Yahoo Finance· 8 hours agoUpdated data from a clinical study shows that treatment with Mustang Bio's (MBIO) experimental cell...
Lantern Pharma secures Japan patent for cancer drug By Investing.com
Investing.com· 6 days agoThe Japan Patent Office issued the certificate for the molecule, which is currently in a Phase 1...
What Is a T-Cell Lymphoproliferative Disorder? Inside Halsey's Diagnosis
Health.com· 7 days agoHalsey, 29, was diagnosed and treated for both lupus and a rare white blood cell disorder, according...
Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with...
Benzinga· 3 days agoDr. Kim Linton, M.B.Ch.B, MRCP, Ph.D., FRCP, senior lecturer at the...
CAR-T Treatment Continues to Astonish in Rheumatologic Diseases
MedPage Today· 7 days agoNew data reported here reinforce the idea that chimeric antigen receptor T-cell (CAR-T) therapy can...